跳至主要内容
临床试验/NCT01698671
NCT01698671Unknown不适用

InterGard Synergy Post-Marketing Surveillance Study

Maquet Cardiovascular3 个研究点 分布在 2 个国家目标入组 50 人开始时间: 2012年10月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
50
试验地点
3
主要终点
Graft Patency and Complications

研究概览

简要总结

The purpose of the study is to assess the performance and safety of the InterGard Synergy vascular graft.

详细描述

Study of the device in patients with aneurysmal and occlusive disease of the abdominal aorta and peripheral arteries.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients requiring an InterGard Synergy Vascular Graft

排除标准

  • Patients with contra-indications per InterGard Synergy Vascular Graft
  • Patients with current graft infection
  • Patients with a known allergy to collagen, triclosan or silver acetate
  • Patients who require urgent or emergent surgery

结局指标

主要结局

Graft Patency and Complications

时间窗: 6 months

* Patency will be assessed by color-coded duplex ultrasound up to 6 months post implantation. * Complications including the occurrence of graft infections will be assessed up to post implantation.

次要结局

  • Mortality rate(6 months)

研究者

发起方
Maquet Cardiovascular
申办方类型
Industry
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验